Filaggrin mutations and atopy: consequences for future therapeutics

References

• O’Regan G, Sandilands A, McLean I, Irvine A. Filaggrin in atopic dermatitis. J. Allergy Clin. Immunol.122, 689–693 (2008).
   PubMed Web of Science ®Google Scholar
• Miscke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex (“epidermal differentiation complex”) on human chromosome 1q21. J. Investigative Dermatol.106, 989–992 (1996).
   PubMedGoogle Scholar
• Rawlings AV, Harding CR. Moisturization and skin barrier function. Dermatol. Ther.17(Suppl. I), 43–48 (2004).
   PubMedGoogle Scholar
• Smith F, Irvine A, Terron-Kwaitkowski A et al. Loss of function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat. Genet.38, 337–342 (2006).
   PubMed Web of Science ®Google Scholar
• Chen H, Common JEA, Haines RL et al. Wide Spectrum of filaggrin null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br. J. Dematol.165, 106–114 (2011).
   PubMed Web of Science ®Google Scholar
• Irvine AD, McLean I, Leung D. Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med.365, 1315–1327 (2011).
   PubMed Web of Science ®Google Scholar
• Weidinger S, O’Sullivan M, Illig T et al. Filaggrin mutations, atopic eczema, hay fever and asthma in children. JACI121, 1203–1209 (2008).
   PubMed Web of Science ®Google Scholar
• Palmer C, Irvine A, Terron-Kwaitkowski A et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet.38, 441–446 (2006).
   PubMed Web of Science ®Google Scholar
• Cookson W. The immunogenetics of asthma and eczema – a new focus on the epithelium. Nat. Rev. Immunol.4, 978–988 (2004).
   PubMed Web of Science ®Google Scholar
• Weidinger S, Illig T, Baurecht H et al. Loss of function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitization. JACI118, 214–219 (2006).
   PubMed Web of Science ®Google Scholar
• O’Regan G, Kemperman P, Sandilands A et al. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. JACI126, 574–580 (2010).
   PubMed Web of Science ®Google Scholar
• Marenholz I, Nickel R, Ruschendorf F et al. Filaggrin loss of function mutations predispose to phenotypes involved in the atopic march. JACI118, 866–871 (2006).
   PubMed Web of Science ®Google Scholar
• Rodriguez E, Baurecht H, Herberich E et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. JACI123, 1361–1370 (2009).
   PubMed Web of Science ®Google Scholar
• Henderson J, Northstone K, Lee SP et al. The burden of disease associated with filaggrin mutations; a population based longitudinal birth cohort study. JACI121, 872–877 (2008).
   PubMedGoogle Scholar
• Irvine A. Fleshing out filaggrin phenotypes. J. Invest. Dermatol.127, 504–507 (2007).
   PubMed Web of Science ®Google Scholar
• Howell M, Kim B, Gao P et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. JACI120, 150–155 (2007).
   PubMed Web of Science ®Google Scholar
• Miajlovic H, Fallon P, Irvine A, Foster T. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. JACI126, 1184–1190 (2010).
   PubMed Web of Science ®Google Scholar
• Kezic S, Kammeyer A, Calkroen F, Fluhr JW, Bos JD. Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br. J. Dermatol.161, 1098–1104 (2009).
   PubMed Web of Science ®Google Scholar
• Gao P, Rafaels NM, Hand T et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. JACI124, 507–513 (2009).
   PubMed Web of Science ®Google Scholar
• Oyoshi MK, Murphy GF, Geha RS. Filaggrin-deficient mice exhibit Th-17 dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. JACI124, 485–493 (2009).
   PubMed Web of Science ®Google Scholar
• Jakasa I, Koster E, Calkoen F et al. Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss of function mutations. J. Invest. Dermatol.131, 540–542 (2011).
   PubMedGoogle Scholar
• Nemoto-Hasebe I, Akiyama A, Nomura T, Sandilands A, McLean W, Shimizu H. Clinical severity correlates with impaired barrier in filaggrin-related eczema. J. Invest. Dermatol.129, 682–689 (2009).
   PubMed Web of Science ®Google Scholar
• Flohr C, England K, Radulvic S et al. Filaggrin loss of function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br. J. Dermatol.163, 1333–1336 (2010).
   PubMed Web of Science ®Google Scholar
• Fallon PG, Sasaki T, Sandilands A et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat. Genet.124, 494–525 (2009).
   Google Scholar
• Oyoshi M, Geha R. Filaggrin deficient mice exhibit Th17-dominated skin inflammation and increased susceptibility to inoculation with vaccinia virus. JACI125, AB123 (2010).
   Google Scholar
• Spergel JM, Paller A. Atopic dermatitis and the atopic march. JACI112, S118–S127 (2003).
   PubMedGoogle Scholar
• Illi S, von Mutils E, Lau S, Nickel R, Gruber C, Niggemann B. The natural course of atopic dermatitis from birth to age seven years and the association with asthma. JACI113(5), 925–931 (2004).
   PubMed Web of Science ®Google Scholar
• Gustafsson D, Sjoberg D, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis – a prospective follow up to seven years of age. Allergy55(3), 240–245 (2000).
   PubMed Web of Science ®Google Scholar
• Kondo H, Ichikawa Y, Imokawa G. Percutaneous sensitization with allergens through barrier disrupted skin elicts a Th2 dominant cytokine response. Eur. J. Immunol.28, 769–779 (1998).
   PubMed Web of Science ®Google Scholar
• Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization to protein antigen induces localized allergic dermatitis hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J. Clin. Invest.101, 1614–1622 (1999).
   Google Scholar
• Demehri S, Morimoto M, Holtzman M, Kopan R. Skin-derived TSLP triggers progression from epidermal barrier defects to asthma. PLOS Biol.7(5), e1000067 (2009).
   PubMed Web of Science ®Google Scholar
• Ziegler S, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat. Immunol.11(4), 289–293 (2010).
   PubMed Web of Science ®Google Scholar
• Soumelis V, Recche P, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat. Immunol.3, 673–680 (2002).
   PubMed Web of Science ®Google Scholar
• Palmer C, Ismail T, Lee SP et al. Filaggrin null mutations are associated with increased asthma severity in children and young adults. JACI120, 64–68 (2007).
   PubMed Web of Science ®Google Scholar
• Basu K, Palmer C, Lipworth B et al. Filaggrin null mutations are associated with increased asthma exacerbations in children and young adults. Allergy63, 1211–1217 (2008).
   PubMed Web of Science ®Google Scholar
• Sherrill J, Rothenberg M. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. JACI128, 23–32 (2011).
   PubMed Web of Science ®Google Scholar
• Brown S, Asai Y, Cordell H et al. Loss of function variants in the filaggrin gene are a significant risk factor for peanut allergy. JACI127, 661–667 (2011).
   PubMed Web of Science ®Google Scholar
• Lack G, Fox D, Northstone K, Golding J. Factors Associated with the Development of peanut allergy in childhood. NEJM348(11), 977–985 (2003).
   PubMed Web of Science ®Google Scholar
• Renner E, Hartl D, Rylaarsdam S et al. Comel-Netherton syndrome defined as primary immunodeficiency. JACI124, 536–543 (2009).
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Bieber T. Proactive therapy of atopic dermatitis – an emerging concept. Allergy64, 276–278 (2009).
   PubMed Web of Science ®Google Scholar
• Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics123(5), e808–e814 (2009).
   PubMed Web of Science ®Google Scholar
• Jung T, Stingl G. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. JACI122, 1074–1081 (2008).
   PubMed Web of Science ®Google Scholar
• Darsow U, Wollenberg A, Simon D et al. ETFAD/EADV eczema task force position paper on diagnosis and treatment of atopic dermatitis. J. Eur. Acad. Dermatol. Venereol.24, 317–328 (2010).
   PubMed Web of Science ®Google Scholar
• Park KK, Kamangar F, Heller M et al. Instant barrier repair: a pilot study investigating occlusion with a new hydrogel patch for the treatment of atopic dermatitis. J. Dermatolog. Treat. doi:10.3109/0954663.2011.594871 (2011) (Epub ahead of print).
   Google Scholar
• Jensen J, Pfeiffer S, Witt M et al. Different effects of pimecrolimus and βmethasone on the skin barrier in patients with atopic dermatitis. JACI123, 1124–1133 (2009).
   PubMed Web of Science ®Google Scholar
• Hanifin JM, Boguniewicz M, Eichenfield LF et al. A long term study of safety and allergic comorbiditiy development in a randomized trial of pimecrolimus cream in infants with atopic dermatitis. J. Allergy Clin. Immunol.119(1), S209 (2007) (Abstract).
   Google Scholar
• Boguniewicz M, Leung D. Recent insights into atopic dermatitis and implications for management of infectious complications. JACI125, 4–13 (2010).
   PubMed Web of Science ®Google Scholar
• Sandilands A, Sutherland C, Irvine AD, McLean WH. Filaggrin in the frontline: role in skin barrier function and disease. J. Cell Sci.122, 1285–1294 (2009).
   PubMed Web of Science ®Google Scholar
• Brown S, McLean I. Eczema genetics: current state of knowledge and future goals. J. Investig. Dermatol.129, 543–552 (2009).
   PubMed Web of Science ®Google Scholar